Pastan I - Search Results

1

Selective elimination of human regulatory T lymphocytes in vitro with the recombinant immunotoxin LMB-2.

Attia P, Powell DJ Jr, Maker AV, Kreitman RJ, Pastan I, Rosenberg SA. Attia P, et al. Among authors: pastan i. J Immunother. 2006 Mar-Apr;29(2):208-14. doi: 10.1097/01.cji.0000187959.45803.0c. J Immunother. 2006. PMID: 16531821 Free PMC article.

2

Intrathecal administration of single-chain immunotoxin, LMB-7 [B3(Fv)-PE38], produces cures of carcinomatous meningitis in a rat model.

Pastan IH, Archer GE, McLendon RE, Friedman HS, Fuchs HE, Wang QC, Pai LH, Herndon J, Bigner DD. Pastan IH, et al. Proc Natl Acad Sci U S A. 1995 Mar 28;92(7):2765-9. doi: 10.1073/pnas.92.7.2765. Proc Natl Acad Sci U S A. 1995. PMID: 7708720 Free PMC article.

3

Sensitization of B-cell chronic lymphocytic leukemia cells to recombinant immunotoxin by immunostimulatory phosphorothioate oligodeoxynucleotides.

Decker T, Hipp S, Kreitman RJ, Pastan I, Peschel C, Licht T. Decker T, et al. Among authors: pastan i. Blood. 2002 Feb 15;99(4):1320-6. Blood. 2002. PMID: 11830482 Free article.

4

Improved cytotoxic activity toward cell lines and fresh leukemia cells of a mutant anti-CD22 immunotoxin obtained by antibody phage display.

Salvatore G, Beers R, Margulies I, Kreitman RJ, Pastan I. Salvatore G, et al. Among authors: pastan i. Clin Cancer Res. 2002 Apr;8(4):995-1002. Clin Cancer Res. 2002. PMID: 11948105

5

Novel anti-CD30 recombinant immunotoxins containing disulfide-stabilized Fv fragments.

Nagata S, Onda M, Numata Y, Santora K, Beers R, Kreitman RJ, Pastan I. Nagata S, et al. Among authors: pastan i. Clin Cancer Res. 2002 Jul;8(7):2345-55. Clin Cancer Res. 2002. PMID: 12114439

6

Immunotoxins in cancer therapy.

Pastan I, Kreitman RJ. Pastan I, et al. Curr Opin Investig Drugs. 2002 Jul;3(7):1089-91. Curr Opin Investig Drugs. 2002. PMID: 12186272 Review.

7

Immunobiological treatments of hairy-cell leukaemia.

Kreitman RJ, Pastan I. Kreitman RJ, et al. Among authors: pastan i. Best Pract Res Clin Haematol. 2003 Mar;16(1):117-33. doi: 10.1016/s1521-6926(03)00003-3. Best Pract Res Clin Haematol. 2003. PMID: 12670470 Review.

8

Induction of caspase-dependent programmed cell death in B-cell chronic lymphocytic leukemia by anti-CD22 immunotoxins.

Decker T, Oelsner M, Kreitman RJ, Salvatore G, Wang QC, Pastan I, Peschel C, Licht T. Decker T, et al. Among authors: pastan i. Blood. 2004 Apr 1;103(7):2718-26. doi: 10.1182/blood-2003-04-1317. Epub 2003 Oct 2. Blood. 2004. PMID: 14525789 Free article.

9

Pretreatment with rituximab does not inhibit the human immune response against the immunogenic protein LMB-1.

Hassan R, Williams-Gould J, Watson T, Pai-Scherf L, Pastan I. Hassan R, et al. Among authors: pastan i. Clin Cancer Res. 2004 Jan 1;10(1 Pt 1):16-8. doi: 10.1158/1078-0432.ccr-1160-3. Clin Cancer Res. 2004. PMID: 14734446 Clinical Trial.

10

In vitro and in vivo cytotoxic activities of recombinant immunotoxin 8H9(Fv)-PE38 against breast cancer, osteosarcoma, and neuroblastoma.

Onda M, Wang QC, Guo HF, Cheung NK, Pastan I. Onda M, et al. Among authors: pastan i. Cancer Res. 2004 Feb 15;64(4):1419-24. doi: 10.1158/0008-5472.can-03-0570. Cancer Res. 2004. PMID: 14973056

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,282 results

Search Page

Filters